| UniProt ID | LAS1L_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y4W2 | |
| Protein Name | Ribosomal biogenesis protein LAS1L | |
| Gene Name | LAS1L | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 734 | |
| Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm. Cytoplasm. Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (By similarity). Localizes mainly to the granular component, the region implicated in the later | |
| Protein Description | Involved in the biogenesis of the 60S ribosomal subunit. Required for maturation of the 28S rRNA. Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes.. | |
| Protein Sequence | MSWESGAGPGLGSQGMDLVWSAWYGKCVKGKGSLPLSAHGIVVAWLSRAEWDQVTVYLFCDDHKLQRYALNRITVWRSRSGNELPLAVASTADLIRCKLLDVTGGLGTDELRLLYGMALVRFVNLISERKTKFAKVPLKCLAQEVNIPDWIVDLRHELTHKKMPHINDCRRGCYFVLDWLQKTYWCRQLENSLRETWELEEFREGIEEEDQEEDKNIVVDDITEQKPEPQDDGKSTESDVKADGDSKGSEEVDSHCKKALSHKELYERARELLVSYEEEQFTVLEKFRYLPKAIKAWNNPSPRVECVLAELKGVTCENREAVLDAFLDDGFLVPTFEQLAALQIEYEDGQTEVQRGEGTDPKSHKNVDLNDVLVPKPFSQFWQPLLRGLHSQNFTQALLERMLSELPALGISGIRPTYILRWTVELIVANTKTGRNARRFSAGQWEARRGWRLFNCSASLDWPRMVESCLGSPCWASPQLLRIIFKAMGQGLPDEEQEKLLRICSIYTQSGENSLVQEGSEASPIGKSPYTLDSLYWSVKPASSSFGSEAKAQQQEEQGSVNDVKEEEKEEKEVLPDQVEEEEENDDQEEEEEDEDDEDDEEEDRMEVGPFSTGQESPTAENARLLAQKRGALQGSAWQVSSEDVRWDTFPLGRMPGQTEDPAELMLENYDTMYLLDQPVLEQRLEPSTCKTDTLGLSCGVGSGNCSNSSSSNFEGLLWSQGQLHGLKTGLQLF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSWESGAGP ------CCCCCCCCC | 39.28 | 28348404 | |
| 5 | Phosphorylation | ---MSWESGAGPGLG ---CCCCCCCCCCCC | 27.90 | 28348404 | |
| 13 | Phosphorylation | GAGPGLGSQGMDLVW CCCCCCCHHCCHHHH | 28.71 | 28348404 | |
| 21 | Phosphorylation | QGMDLVWSAWYGKCV HCCHHHHHEECCCCC | 11.05 | 28674151 | |
| 24 | Phosphorylation | DLVWSAWYGKCVKGK HHHHHEECCCCCCCC | 13.36 | 28674151 | |
| 31 | Acetylation | YGKCVKGKGSLPLSA CCCCCCCCCCCCCCC | 39.34 | 26051181 | |
| 31 | Ubiquitination | YGKCVKGKGSLPLSA CCCCCCCCCCCCCCC | 39.34 | - | |
| 60 | Ubiquitination | QVTVYLFCDDHKLQR EEEEEEEECCHHHHH | 5.77 | 22817900 | |
| 63 | Ubiquitination | VYLFCDDHKLQRYAL EEEEECCHHHHHHHH | 21.34 | 21890473 | |
| 64 | Ubiquitination | YLFCDDHKLQRYALN EEEECCHHHHHHHHH | 54.00 | 21963094 | |
| 80 | Phosphorylation | ITVWRSRSGNELPLA EEEEECCCCCCCCEE | 47.41 | 20068231 | |
| 90 | Phosphorylation | ELPLAVASTADLIRC CCCEEEEHHHHHHHC | 19.96 | 20068231 | |
| 91 | Phosphorylation | LPLAVASTADLIRCK CCEEEEHHHHHHHCE | 17.91 | 20068231 | |
| 93 | Ubiquitination | LAVASTADLIRCKLL EEEEHHHHHHHCEEC | 42.59 | 29901268 | |
| 97 | Ubiquitination | STADLIRCKLLDVTG HHHHHHHCEECCCCC | 2.63 | 21963094 | |
| 97 (in isoform 3) | Ubiquitination | - | 2.63 | 21890473 | |
| 98 | Ubiquitination | TADLIRCKLLDVTGG HHHHHHCEECCCCCC | 42.08 | 21963094 | |
| 115 | Phosphorylation | TDELRLLYGMALVRF HHHHHHHHHHHHHHH | 14.94 | - | |
| 119 | Ubiquitination | RLLYGMALVRFVNLI HHHHHHHHHHHHHHH | 1.79 | 29967540 | |
| 120 | Ubiquitination | LLYGMALVRFVNLIS HHHHHHHHHHHHHHC | 3.03 | 27667366 | |
| 127 | O-linked_Glycosylation | VRFVNLISERKTKFA HHHHHHHCCCCCCCC | 34.22 | 30379171 | |
| 127 | Phosphorylation | VRFVNLISERKTKFA HHHHHHHCCCCCCCC | 34.22 | 20068231 | |
| 135 | Acetylation | ERKTKFAKVPLKCLA CCCCCCCCCCHHHHH | 47.74 | 26051181 | |
| 135 | Ubiquitination | ERKTKFAKVPLKCLA CCCCCCCCCCHHHHH | 47.74 | 27667366 | |
| 139 | Methylation | KFAKVPLKCLAQEVN CCCCCCHHHHHHHCC | 22.57 | 30783411 | |
| 139 | Ubiquitination | KFAKVPLKCLAQEVN CCCCCCHHHHHHHCC | 22.57 | 21906983 | |
| 139 (in isoform 1) | Ubiquitination | - | 22.57 | 21890473 | |
| 139 (in isoform 2) | Ubiquitination | - | 22.57 | 21890473 | |
| 139 (in isoform 4) | Ubiquitination | - | 22.57 | 21890473 | |
| 140 | Glutathionylation | FAKVPLKCLAQEVNI CCCCCHHHHHHHCCC | 5.12 | 22555962 | |
| 161 | Ubiquitination | LRHELTHKKMPHIND HHHHHHCCCCCCHHH | 45.60 | 29967540 | |
| 162 | Ubiquitination | RHELTHKKMPHINDC HHHHHCCCCCCHHHH | 50.49 | 27667366 | |
| 167 | Ubiquitination | HKKMPHINDCRRGCY CCCCCCHHHHHHCHH | 39.02 | 27667366 | |
| 173 | Ubiquitination | INDCRRGCYFVLDWL HHHHHHCHHHHHHHH | 1.95 | 29967540 | |
| 180 | Ubiquitination | CYFVLDWLQKTYWCR HHHHHHHHHHHHHHH | 3.60 | 21963094 | |
| 184 | Ubiquitination | LDWLQKTYWCRQLEN HHHHHHHHHHHHHHH | 15.00 | 27667366 | |
| 184 (in isoform 3) | Ubiquitination | - | 15.00 | 21890473 | |
| 192 | Ubiquitination | WCRQLENSLRETWEL HHHHHHHHHHHHCHH | 21.30 | 29967540 | |
| 197 | Ubiquitination | ENSLRETWELEEFRE HHHHHHHCHHHHHHH | 11.92 | 21890473 | |
| 199 | Ubiquitination | SLRETWELEEFREGI HHHHHCHHHHHHHCC | 6.03 | 33845483 | |
| 199 (in isoform 3) | Ubiquitination | - | 6.03 | 21890473 | |
| 205 | Ubiquitination | ELEEFREGIEEEDQE HHHHHHHCCCHHHHH | 28.49 | 27667366 | |
| 215 | Sumoylation | EEDQEEDKNIVVDDI HHHHHHHCCCEEEEH | 52.43 | 28112733 | |
| 215 | Ubiquitination | EEDQEEDKNIVVDDI HHHHHHHCCCEEEEH | 52.43 | 29967540 | |
| 215 (in isoform 3) | Ubiquitination | - | 52.43 | 21890473 | |
| 216 | Ubiquitination | EDQEEDKNIVVDDIT HHHHHHCCCEEEEHH | 44.61 | 22817900 | |
| 221 | Ubiquitination | DKNIVVDDITEQKPE HCCCEEEEHHCCCCC | 37.79 | 27667366 | |
| 221 (in isoform 3) | Ubiquitination | - | 37.79 | 21890473 | |
| 223 | Phosphorylation | NIVVDDITEQKPEPQ CCEEEEHHCCCCCCC | 39.08 | 30576142 | |
| 226 | Sumoylation | VDDITEQKPEPQDDG EEEHHCCCCCCCCCC | 45.15 | - | |
| 226 | Sumoylation | VDDITEQKPEPQDDG EEEHHCCCCCCCCCC | 45.15 | 28112733 | |
| 226 | Ubiquitination | VDDITEQKPEPQDDG EEEHHCCCCCCCCCC | 45.15 | 21906983 | |
| 226 (in isoform 1) | Ubiquitination | - | 45.15 | 21890473 | |
| 226 (in isoform 2) | Ubiquitination | - | 45.15 | 21890473 | |
| 226 (in isoform 4) | Ubiquitination | - | 45.15 | 21890473 | |
| 234 | Ubiquitination | PEPQDDGKSTESDVK CCCCCCCCCCHHHHH | 62.29 | 29967540 | |
| 235 | Phosphorylation | EPQDDGKSTESDVKA CCCCCCCCCHHHHHC | 42.83 | 23927012 | |
| 236 | Phosphorylation | PQDDGKSTESDVKAD CCCCCCCCHHHHHCC | 42.89 | 25159151 | |
| 238 | Phosphorylation | DDGKSTESDVKADGD CCCCCCHHHHHCCCC | 48.03 | 23401153 | |
| 238 | Ubiquitination | DDGKSTESDVKADGD CCCCCCHHHHHCCCC | 48.03 | 21963094 | |
| 241 | Phosphorylation | KSTESDVKADGDSKG CCCHHHHHCCCCCCC | 45.83 | 32142685 | |
| 241 | Ubiquitination | KSTESDVKADGDSKG CCCHHHHHCCCCCCC | 45.83 | 21906983 | |
| 241 (in isoform 1) | Ubiquitination | - | 45.83 | 21890473 | |
| 241 (in isoform 2) | Ubiquitination | - | 45.83 | 21890473 | |
| 241 (in isoform 4) | Ubiquitination | - | 45.83 | 21890473 | |
| 244 | Ubiquitination | ESDVKADGDSKGSEE HHHHHCCCCCCCHHH | 46.05 | 21963094 | |
| 244 (in isoform 3) | Ubiquitination | - | 46.05 | 21890473 | |
| 246 | Phosphorylation | DVKADGDSKGSEEVD HHHCCCCCCCHHHHH | 44.43 | 28985074 | |
| 246 | Ubiquitination | DVKADGDSKGSEEVD HHHCCCCCCCHHHHH | 44.43 | 27667366 | |
| 247 | Ubiquitination | VKADGDSKGSEEVDS HHCCCCCCCHHHHHH | 71.80 | 27667366 | |
| 249 | Phosphorylation | ADGDSKGSEEVDSHC CCCCCCCHHHHHHHH | 34.03 | 25849741 | |
| 250 | Ubiquitination | DGDSKGSEEVDSHCK CCCCCCHHHHHHHHH | 71.37 | 29901268 | |
| 253 | Ubiquitination | SKGSEEVDSHCKKAL CCCHHHHHHHHHHHH | 35.62 | 21963094 | |
| 253 (in isoform 3) | Ubiquitination | - | 35.62 | 21890473 | |
| 254 | Phosphorylation | KGSEEVDSHCKKALS CCHHHHHHHHHHHHC | 35.64 | 28985074 | |
| 257 | Ubiquitination | EEVDSHCKKALSHKE HHHHHHHHHHHCHHH | 35.34 | 21906983 | |
| 257 (in isoform 1) | Ubiquitination | - | 35.34 | 21890473 | |
| 257 (in isoform 2) | Ubiquitination | - | 35.34 | 21890473 | |
| 257 (in isoform 4) | Ubiquitination | - | 35.34 | 21890473 | |
| 258 | Ubiquitination | EVDSHCKKALSHKEL HHHHHHHHHHCHHHH | 61.01 | 22817900 | |
| 261 | Phosphorylation | SHCKKALSHKELYER HHHHHHHCHHHHHHH | 37.06 | - | |
| 263 | Ubiquitination | CKKALSHKELYERAR HHHHHCHHHHHHHHH | 46.14 | 21890473 | |
| 263 | Acetylation | CKKALSHKELYERAR HHHHHCHHHHHHHHH | 46.14 | 26051181 | |
| 263 | Ubiquitination | CKKALSHKELYERAR HHHHHCHHHHHHHHH | 46.14 | 27667366 | |
| 263 (in isoform 1) | Ubiquitination | - | 46.14 | 21890473 | |
| 263 (in isoform 2) | Ubiquitination | - | 46.14 | 21890473 | |
| 263 (in isoform 4) | Ubiquitination | - | 46.14 | 21890473 | |
| 270 | Ubiquitination | KELYERARELLVSYE HHHHHHHHHHHHCCC | 41.12 | 21963094 | |
| 270 (in isoform 3) | Ubiquitination | - | 41.12 | 21890473 | |
| 286 | Ubiquitination | EQFTVLEKFRYLPKA HHHHHHHHHCCHHHH | 30.86 | 21906983 | |
| 286 (in isoform 1) | Ubiquitination | - | 30.86 | 21890473 | |
| 286 (in isoform 2) | Ubiquitination | - | 30.86 | 21890473 | |
| 292 | Malonylation | EKFRYLPKAIKAWNN HHHCCHHHHHHHHCC | 61.21 | 32601280 | |
| 292 | Ubiquitination | EKFRYLPKAIKAWNN HHHCCHHHHHHHHCC | 61.21 | 29901268 | |
| 295 | Sumoylation | RYLPKAIKAWNNPSP CCHHHHHHHHCCCCH | 52.81 | - | |
| 295 | Malonylation | RYLPKAIKAWNNPSP CCHHHHHHHHCCCCH | 52.81 | 26320211 | |
| 295 | Sumoylation | RYLPKAIKAWNNPSP CCHHHHHHHHCCCCH | 52.81 | - | |
| 295 | Ubiquitination | RYLPKAIKAWNNPSP CCHHHHHHHHCCCCH | 52.81 | 21906983 | |
| 295 (in isoform 1) | Ubiquitination | - | 52.81 | 21890473 | |
| 295 (in isoform 2) | Ubiquitination | - | 52.81 | 21890473 | |
| 298 | Phosphorylation | PKAIKAWNNPSPRVE HHHHHHHCCCCHHHH | 56.23 | 33259812 | |
| 301 | Phosphorylation | IKAWNNPSPRVECVL HHHHCCCCHHHHHHH | 27.71 | 25159151 | |
| 310 | Ubiquitination | RVECVLAELKGVTCE HHHHHHHHHCCCCCC | 47.02 | 27667366 | |
| 312 | Acetylation | ECVLAELKGVTCENR HHHHHHHCCCCCCCH | 42.72 | 25953088 | |
| 312 | Ubiquitination | ECVLAELKGVTCENR HHHHHHHCCCCCCCH | 42.72 | 21906983 | |
| 312 (in isoform 1) | Ubiquitination | - | 42.72 | 21890473 | |
| 312 (in isoform 2) | Ubiquitination | - | 42.72 | 21890473 | |
| 320 | Ubiquitination | GVTCENREAVLDAFL CCCCCCHHHHHHHHC | 55.50 | 22817900 | |
| 323 | Ubiquitination | CENREAVLDAFLDDG CCCHHHHHHHHCCCC | 5.18 | 21890473 | |
| 327 | Ubiquitination | EAVLDAFLDDGFLVP HHHHHHHCCCCCCCC | 6.68 | 27667366 | |
| 362 | Ubiquitination | RGEGTDPKSHKNVDL CCCCCCCCCCCCCCH | 68.92 | 22817900 | |
| 363 | Phosphorylation | GEGTDPKSHKNVDLN CCCCCCCCCCCCCHH | 45.11 | - | |
| 365 | Ubiquitination | GTDPKSHKNVDLNDV CCCCCCCCCCCHHHC | 66.80 | 21890473 | |
| 365 | Ubiquitination | GTDPKSHKNVDLNDV CCCCCCCCCCCHHHC | 66.80 | 21890473 | |
| 365 (in isoform 1) | Ubiquitination | - | 66.80 | 21890473 | |
| 372 | Ubiquitination | KNVDLNDVLVPKPFS CCCCHHHCCCCCCHH | 5.89 | 21963094 | |
| 373 (in isoform 3) | Ubiquitination | - | 6.43 | 21890473 | |
| 376 | Ubiquitination | LNDVLVPKPFSQFWQ HHHCCCCCCHHHHHH | 51.74 | 33845483 | |
| 389 | Ubiquitination | WQPLLRGLHSQNFTQ HHHHHHHHHCCCHHH | 2.58 | 21963094 | |
| 404 | Phosphorylation | ALLERMLSELPALGI HHHHHHHHHCHHHCC | 27.95 | 20068231 | |
| 412 | Phosphorylation | ELPALGISGIRPTYI HCHHHCCCCCCCCEE | 26.77 | 20068231 | |
| 415 (in isoform 2) | Ubiquitination | - | 22.49 | 21890473 | |
| 417 | Phosphorylation | GISGIRPTYILRWTV CCCCCCCCEEHHEEE | 17.22 | 20068231 | |
| 418 | Phosphorylation | ISGIRPTYILRWTVE CCCCCCCEEHHEEEE | 10.71 | 22210691 | |
| 427 | Ubiquitination | LRWTVELIVANTKTG HHEEEEEEEEECCCC | 1.41 | 27667366 | |
| 427 (in isoform 3) | Ubiquitination | - | 1.41 | 21890473 | |
| 432 | Ubiquitination | ELIVANTKTGRNARR EEEEEECCCCCCCHH | 49.11 | 21906983 | |
| 432 (in isoform 1) | Ubiquitination | - | 49.11 | 21890473 | |
| 440 | Ubiquitination | TGRNARRFSAGQWEA CCCCCHHCCCCCCHH | 4.97 | 21963094 | |
| 440 (in isoform 3) | Ubiquitination | - | 4.97 | 21890473 | |
| 441 | Phosphorylation | GRNARRFSAGQWEAR CCCCHHCCCCCCHHH | 29.67 | 28450419 | |
| 444 | Ubiquitination | ARRFSAGQWEARRGW CHHCCCCCCHHHCCE | 34.26 | 27667366 | |
| 457 | Ubiquitination | GWRLFNCSASLDWPR CEEEEEEEECCCHHH | 23.23 | 21890473 | |
| 469 | Ubiquitination | WPRMVESCLGSPCWA HHHHHHHHHCCCCCC | 2.93 | 27667366 | |
| 469 (in isoform 2) | Ubiquitination | - | 2.93 | 21890473 | |
| 477 | Phosphorylation | LGSPCWASPQLLRII HCCCCCCCHHHHHHH | 6.67 | 21815630 | |
| 481 | Ubiquitination | CWASPQLLRIIFKAM CCCCHHHHHHHHHHH | 2.88 | 21963094 | |
| 481 (in isoform 3) | Ubiquitination | - | 2.88 | 21890473 | |
| 482 | Ubiquitination | WASPQLLRIIFKAMG CCCHHHHHHHHHHHC | 28.66 | 21963094 | |
| 482 (in isoform 2) | Ubiquitination | - | 28.66 | 21890473 | |
| 486 | Ubiquitination | QLLRIIFKAMGQGLP HHHHHHHHHHCCCCC | 27.36 | 21890473 | |
| 486 | Acetylation | QLLRIIFKAMGQGLP HHHHHHHHHHCCCCC | 27.36 | 26051181 | |
| 486 | Ubiquitination | QLLRIIFKAMGQGLP HHHHHHHHHHCCCCC | 27.36 | 27667366 | |
| 486 (in isoform 1) | Ubiquitination | - | 27.36 | 21890473 | |
| 492 | Ubiquitination | FKAMGQGLPDEEQEK HHHHCCCCCHHHHHH | 3.57 | 29967540 | |
| 498 | Ubiquitination | GLPDEEQEKLLRICS CCCHHHHHHHHHHHH | 49.29 | 21963094 | |
| 499 | Ubiquitination | LPDEEQEKLLRICSI CCHHHHHHHHHHHHH | 53.14 | 21890473 | |
| 499 | Acetylation | LPDEEQEKLLRICSI CCHHHHHHHHHHHHH | 53.14 | 26051181 | |
| 499 | Ubiquitination | LPDEEQEKLLRICSI CCHHHHHHHHHHHHH | 53.14 | 21963094 | |
| 499 (in isoform 1) | Ubiquitination | - | 53.14 | 21890473 | |
| 501 | Phosphorylation | DEEQEKLLRICSIYT HHHHHHHHHHHHHHC | 5.27 | 32142685 | |
| 505 | Phosphorylation | EKLLRICSIYTQSGE HHHHHHHHHHCCCCC | 19.09 | 29255136 | |
| 506 | Ubiquitination | KLLRICSIYTQSGEN HHHHHHHHHCCCCCC | 3.60 | 27667366 | |
| 506 (in isoform 3) | Ubiquitination | - | 3.60 | 21890473 | |
| 507 | Phosphorylation | LLRICSIYTQSGENS HHHHHHHHCCCCCCC | 5.17 | 29255136 | |
| 508 | Phosphorylation | LRICSIYTQSGENSL HHHHHHHCCCCCCCC | 18.00 | 29255136 | |
| 510 | Phosphorylation | ICSIYTQSGENSLVQ HHHHHCCCCCCCCCC | 40.03 | 29255136 | |
| 514 | Phosphorylation | YTQSGENSLVQEGSE HCCCCCCCCCCCCCC | 26.14 | 29255136 | |
| 520 | Phosphorylation | NSLVQEGSEASPIGK CCCCCCCCCCCCCCC | 29.27 | 30266825 | |
| 523 | Phosphorylation | VQEGSEASPIGKSPY CCCCCCCCCCCCCCC | 17.01 | 29255136 | |
| 523 | Ubiquitination | VQEGSEASPIGKSPY CCCCCCCCCCCCCCC | 17.01 | 27667366 | |
| 523 (in isoform 2) | Ubiquitination | - | 17.01 | 21890473 | |
| 528 | Phosphorylation | EASPIGKSPYTLDSL CCCCCCCCCCCHHHH | 20.23 | 21945579 | |
| 530 | Phosphorylation | SPIGKSPYTLDSLYW CCCCCCCCCHHHHEE | 27.33 | 21945579 | |
| 531 | Phosphorylation | PIGKSPYTLDSLYWS CCCCCCCCHHHHEEE | 27.72 | 21945579 | |
| 534 | Phosphorylation | KSPYTLDSLYWSVKP CCCCCHHHHEEECCC | 26.86 | 21945579 | |
| 534 | Ubiquitination | KSPYTLDSLYWSVKP CCCCCHHHHEEECCC | 26.86 | 29967540 | |
| 536 | Phosphorylation | PYTLDSLYWSVKPAS CCCHHHHEEECCCCC | 10.29 | 21945579 | |
| 538 | Phosphorylation | TLDSLYWSVKPASSS CHHHHEEECCCCCCC | 13.50 | 21945579 | |
| 540 | Acetylation | DSLYWSVKPASSSFG HHHEEECCCCCCCCC | 29.38 | 26051181 | |
| 540 | Ubiquitination | DSLYWSVKPASSSFG HHHEEECCCCCCCCC | 29.38 | 21906983 | |
| 540 (in isoform 1) | Ubiquitination | - | 29.38 | 21890473 | |
| 543 | Phosphorylation | YWSVKPASSSFGSEA EEECCCCCCCCCHHH | 34.73 | 25159151 | |
| 544 | Phosphorylation | WSVKPASSSFGSEAK EECCCCCCCCCHHHH | 31.62 | 26074081 | |
| 545 | Phosphorylation | SVKPASSSFGSEAKA ECCCCCCCCCHHHHH | 31.00 | 21945579 | |
| 548 | Phosphorylation | PASSSFGSEAKAQQQ CCCCCCCHHHHHHHH | 32.16 | 25159151 | |
| 548 | Ubiquitination | PASSSFGSEAKAQQQ CCCCCCCHHHHHHHH | 32.16 | 27667366 | |
| 548 (in isoform 2) | Ubiquitination | - | 32.16 | 21890473 | |
| 551 | Ubiquitination | SSFGSEAKAQQQEEQ CCCCHHHHHHHHHHC | 42.55 | 29967540 | |
| 558 | Phosphorylation | KAQQQEEQGSVNDVK HHHHHHHCCCCCHHH | 49.02 | 33259812 | |
| 560 | Phosphorylation | QQQEEQGSVNDVKEE HHHHHCCCCCHHHHH | 19.90 | 29255136 | |
| 565 | Sumoylation | QGSVNDVKEEEKEEK CCCCCHHHHHHHHHH | 63.37 | - | |
| 565 | Sumoylation | QGSVNDVKEEEKEEK CCCCCHHHHHHHHHH | 63.37 | - | |
| 565 | Ubiquitination | QGSVNDVKEEEKEEK CCCCCHHHHHHHHHH | 63.37 | 27667366 | |
| 565 (in isoform 1) | Ubiquitination | - | 63.37 | 21890473 | |
| 570 | Ubiquitination | DVKEEEKEEKEVLPD HHHHHHHHHHCCCCH | 77.05 | 27667366 | |
| 587 | Ubiquitination | EEEEENDDQEEEEED HHHHHCCCHHHHHCC | 70.17 | 27667366 | |
| 600 | Phosphorylation | EDEDDEDDEEEDRME CCCCCCCCCHHHHHC | 64.26 | 33259812 | |
| 612 | Phosphorylation | RMEVGPFSTGQESPT HHCCCCCCCCCCCCC | 34.46 | 22167270 | |
| 612 | Ubiquitination | RMEVGPFSTGQESPT HHCCCCCCCCCCCCC | 34.46 | 27667366 | |
| 613 | Phosphorylation | MEVGPFSTGQESPTA HCCCCCCCCCCCCCH | 43.17 | 22167270 | |
| 617 | Phosphorylation | PFSTGQESPTAENAR CCCCCCCCCCHHHHH | 21.47 | 19664994 | |
| 619 | Phosphorylation | STGQESPTAENARLL CCCCCCCCHHHHHHH | 56.75 | 30266825 | |
| 629 | Ubiquitination | NARLLAQKRGALQGS HHHHHHHHHCCCCCC | 47.38 | 27667366 | |
| 632 | Ubiquitination | LLAQKRGALQGSAWQ HHHHHHCCCCCCCEE | 10.76 | 21963094 | |
| 641 | Phosphorylation | QGSAWQVSSEDVRWD CCCCEECCCCCCCCC | 16.95 | 29449344 | |
| 642 | Phosphorylation | GSAWQVSSEDVRWDT CCCEECCCCCCCCCC | 38.67 | 28985074 | |
| 649 | Ubiquitination | SEDVRWDTFPLGRMP CCCCCCCCCCCCCCC | 21.86 | 21963094 | |
| 673 | Ubiquitination | MLENYDTMYLLDQPV HHHCCCCEEECCCHH | 1.71 | 21963094 | |
| 674 | Ubiquitination | LENYDTMYLLDQPVL HHCCCCEEECCCHHH | 13.25 | 21963094 | |
| 690 | Ubiquitination | QRLEPSTCKTDTLGL HHCCCCCCCCCCCCC | 5.39 | 21963094 | |
| 691 | Ubiquitination | RLEPSTCKTDTLGLS HCCCCCCCCCCCCCC | 49.91 | 21963094 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LAS1L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LAS1L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LAS1L_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PELP1_HUMAN | PELP1 | physical | 20442285 | |
| PELP1_HUMAN | PELP1 | physical | 22939629 | |
| TEX10_HUMAN | TEX10 | physical | 22939629 | |
| PELP1_HUMAN | PELP1 | physical | 22190735 | |
| IPO5_HUMAN | IPO5 | physical | 22190735 | |
| TEX10_HUMAN | TEX10 | physical | 22190735 | |
| NOL9_HUMAN | NOL9 | physical | 22190735 | |
| SENP3_HUMAN | SENP3 | physical | 22190735 | |
| WDR18_HUMAN | WDR18 | physical | 22190735 | |
| NOL9_HUMAN | NOL9 | physical | 26344197 | |
| PELP1_HUMAN | PELP1 | physical | 26344197 | |
| TEX10_HUMAN | TEX10 | physical | 26344197 | |
| WDR18_HUMAN | WDR18 | physical | 26344197 | |
| RAF1_HUMAN | RAF1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-617, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523 AND SER-560, ANDMASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523, AND MASSSPECTROMETRY. | |